Serum Institute of India: News

Trial will continue: Centre on SII vaccine's "adverse reaction" claims

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

01 Dec 2020

Oxford University

SII says Covishield 'safe' after trial participant sends legal notice

The Serum Institute of India (SII) on Tuesday said that its COVID-19 vaccine candidate was "safe and immunogenic," in response to allegations that a trial participant developed serious side-effects after being administered the dose.

30 Nov 2020


SII to sue vaccine trial participant for Rs. 100 crore

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

28 Nov 2020

Narendra Modi

Applying for Covishield's emergency approval in 2 weeks: SII

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

28 Nov 2020

Narendra Modi

Modi embarks on 3-city tour to view COVID-19 vaccine development

Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.

26 Nov 2020


Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

23 Nov 2020


Can launch 100 million vaccine doses by January-February, says Poonawalla

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

20 Nov 2020

Oxford University

Oxford vaccine to be available by April 2021 in India

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.

14 Nov 2020


India to get 10cr COVID-19 vaccine doses by December: SII

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.

08 Nov 2020

Adar Poonawalla

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

05 Nov 2020


Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

01 Nov 2020


Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

29 Oct 2020


Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

20 Oct 2020


India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

17 Oct 2020


India may get COVID-19 vaccine by March 2021: SII official

India may get a vaccine for COVID-19 by March 2021, the Executive Director of the Serum Institute of India (SII) has said.

12 Oct 2020


COVAXIN to Oxford: Coronavirus vaccine updates for India

Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.

27 Sep 2020


PM's vaccine arrangements will take care of all: Adar Poonawalla

As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.

22 Sep 2020


Vaccine expected by early 2021; nationwide immunization a challenge: Scientist

A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.

21 Sep 2020


COVID-19 vaccine: Serum Institute to start final trials this week

As India's COVID-19 cases continue to surge by nearly a lakh every passing day, scientists are racing to get a vaccine ready as soon as possible.

16 Sep 2020


After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

14 Sep 2020

Independence Day

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

12 Sep 2020


Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

10 Sep 2020


Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

10 Sep 2020

University of Oxford

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

30 Aug 2020


Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute

One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine.

27 Aug 2020

Oxford University

Coronavirus vaccine tracker: When will one be ready?

The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.

19 Aug 2020


India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials

In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.

18 Aug 2020


Indian government starts talks to procure COVID-19 vaccine: Details here

Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.

11 Aug 2020


India likely to have COVID-19 vaccine by December: Adar Poonawalla

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

07 Aug 2020


Serum Institute's COVID-19 vaccines will come at $3 per dose

In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.

06 Aug 2020


India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

03 Aug 2020


SII gets nod for Oxford COVID vaccine phase 2/3 trials

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

24 Jul 2020

Oxford University

Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India

In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.

22 Jul 2020


Coronavirus vaccine will be available by 2021? Adar Poonawalla hopeful

Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.

21 Jul 2020

Oxford University

India: Human trials of Oxford vaccine may start in August

The coronavirus vaccine, developed by researchers at Oxford University, could soon enter human trials phase in India, the CEO of Serum Institute of India informed on Monday.

05 Jul 2020


COVID-19 vaccine: What are the latest updates?

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

07 Jun 2020


COVID-19 vaccine: What are the latest updates?

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.

26 Apr 2020


India will start COVID-19 vaccine production next month: Details here

In a major development, Cyrus S. Poonawalla's Serum Institute of India has confirmed that it will start making a vaccine for COVID-19 next month.

08 Apr 2020

Mukesh Ambani

Amid coronavirus crisis, this Indian business tycoon is growing richer

The outbreak of coronavirus, and the ongoing nation-wide lockdown to prevent it from growing worse, has disrupted businesses so much that their leaders and investors are bleeding money.